A recent study shows low doses of aspirin can reduce the risk of colon cancer.
British researchers found that aspirin reduced the number of cases of colorectal cancer by a quarter and cut colon cancer deaths by a third.
Colon cancer is the second most common form of cancer in developed countries.
The findings were published in the Lancet Medical journal.
Alex has written for Vanity Fair, Barrons, Bloomberg and Condé Nast Traveler.